Literature DB >> 13192203

The mode of action of phenylindanedione.

W WALKER, R B HUNTER.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION/effect of drugs on; PHENINDIONE/effects; PROTHROMBIN TIME/effect of drugs on

Mesh:

Substances:

Year:  1954        PMID: 13192203      PMCID: PMC1023801          DOI: 10.1136/jcp.7.3.249

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  8 in total

1.  Clinical trial of phenylindanedione as an anticoagulant.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1953-03-21

2.  The measurement of prothrombin in plasma; a case of prothrombin deficiency.

Authors:  R BIGGS; A S DOUGLAS
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

3.  Mode of action of tromexan.

Authors:  R B HUNTER; G R TUDHOPE
Journal:  Lancet       Date:  1953-04-25       Impact factor: 79.321

4.  Clinical use of a new anticoagulant, phenylindanedione; report of 400 cases.

Authors:  A BLAUSTEIN; N SHNAYERSON; R WALLACH
Journal:  Am J Med       Date:  1953-06       Impact factor: 4.965

5.  The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.

Authors:  P A OWREN; K AAS
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

6.  The effect of phenylindanedione on plasma prothrombin and factor V levels and a comparison with the effect of dicumarol.

Authors:  C J BJERKELUND
Journal:  Scand J Clin Lab Invest       Date:  1950       Impact factor: 1.713

7.  A new prothrombopenic drug, phenylindanedione.

Authors:  L B JAQUES; E GORDON E LEPP
Journal:  Can Med Assoc J       Date:  1950-05       Impact factor: 8.262

8.  A new prothrombopenic agent.

Authors:  A BLAUSTEIN
Journal:  Can Med Assoc J       Date:  1950-05       Impact factor: 8.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.